T1	Chemical	122 143	fluorouracil exposure
T2	Pharmacodynamic_phenotype	165 201	narrow therapeutic index , nonlinear
T3	Pharmacokinetic_phenotype	202 225	pharmacokinetics , vari
T4	Pharmacokinetic_phenotype	253 262	rates and
T5	Pharmacokinetic_phenotype	263 279	metabolism , and
T6	Gene_or_protein	302 318	ylate synthase .
R1	influences	Arg1:T1	Arg2:T3
R2	influences	Arg1:T1	Arg2:T4
R3	influences	Arg1:T1	Arg2:T6
R4	influences	Arg1:T2	Arg2:T1
R5	influences	Arg1:T2	Arg2:T3
R6	influences	Arg1:T2	Arg2:T4
R7	influences	Arg1:T2	Arg2:T5
R8	influences	Arg1:T2	Arg2:T6
R9	influences	Arg1:T3	Arg2:T1
R10	influences	Arg1:T3	Arg2:T2
R11	influences	Arg1:T3	Arg2:T4
R12	influences	Arg1:T3	Arg2:T5
R13	influences	Arg1:T3	Arg2:T6
R14	influences	Arg1:T4	Arg2:T1
R15	influences	Arg1:T4	Arg2:T2
R16	influences	Arg1:T4	Arg2:T3
R17	influences	Arg1:T4	Arg2:T5
R18	influences	Arg1:T4	Arg2:T6
R19	influences	Arg1:T5	Arg2:T1
R20	influences	Arg1:T5	Arg2:T2
R21	influences	Arg1:T5	Arg2:T3
R22	influences	Arg1:T5	Arg2:T4
R23	influences	Arg1:T5	Arg2:T6
R24	influences	Arg1:T6	Arg2:T1
R25	influences	Arg1:T6	Arg2:T2
R26	influences	Arg1:T6	Arg2:T3
R27	influences	Arg1:T6	Arg2:T4
R28	influences	Arg1:T6	Arg2:T5
